The Open Nitric Oxide Journal

2011, 3 : 65-71
Published online 2011 December 15. DOI: 10.2174/1875042701103010065
Publisher ID: TONOJ-3-65

Nitric Oxide and its Role in Cardiovascular Diseases

Branislava Dobutovic , Katarina Smiljanic , Sanja Soskic , Hans-Dirk Dungen and Esma R. Isenovic
Institute ”Vinca“, University of Belgrade, Laboratory for Radiobiology and Molecular Genetics, P.O.Box 522,11000 Belgrade, Serbia.

ABSTRACT

Nitric oxide synthases (NOS) are the enzymes responsible for nitric oxide (NO) generation. NO is a free radical which reacts with various molecules to cause multiple biological effects. It is clear that the generation and actions of NO under physiological and pathophysiological conditions are exquisitely regulated and extend to almost every cell type and function within the circulation. While the molecule mediates many physiological functions, an excessive presence of NO is toxic to cells. The enzyme NOS, constitutively or inductively, catalyses the production of NO in several biological systems. NO is derived not only from NOS isoforms but also from NOS-independent sources. In mammals, to date, three distinct NOS isoforms have been identified: neuronal NOS (nNOS), inducible NOS (iNOS), and endothelial NOS (eNOS). The molecular structure, enzymology and pharmacology of these enzymes have been well defined, and reveal critical roles for the NOS system in a variety of important physiological processes. This review focuses on recent advances in the understanding of the interactions between NOS enzymes and pathophysiology of cardiovascular diseases (CVD) and the role of NO agonists as potential therapeutic agents in treatment of CVD.

Keywords:

nitric oxide, nitric oxide synthase, endothelial dysfunction, chronic heart failure.